Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Studies into the occurrence of soluble antigen--antibody complexes in disease. I. A biological assay for soluble complexes.

× No keyword cloud information.

17 in total

1. LIVER LOCALIZING ANTIBODIES--THE LIMITED CONTRIBUTION OF AG-AB COMPLEXES.

Authors: D SULITZEANU; Y YAGI; D PRESSMAN
Journal: J Immunol Date: 1964-05 Impact factor: 5.422

2. Preparation of iodine-131 labelled human growth hormone of high specific activity.

Authors: W M HUNTER; F C GREENWOOD
Journal: Nature Date: 1962-05-05 Impact factor: 49.962

3. A study of the mechanism of passive sensitization.

Authors: J L MONGAR; H O SCHILD
Journal: J Physiol Date: 1960-03 Impact factor: 5.182

4. Pathogenesis of serum sickness.

Authors: F J DIXON; J J VAZQUEZ; W O WEIGLE; C G COCHRANE
Journal: AMA Arch Pathol Date: 1958-01

5. A comparative study of methods used for analysis of specific precipitates in quantitative immunochemistry.

Authors: E A KABAT; F C MCDUFFIE
Journal: J Immunol Date: 1956-09 Impact factor: 5.422

6. Improved automatic apparatus for pharmacological assays on isolated preparations.

Authors: A BOURA; J L MONGAR; H O SCHILD
Journal: Br J Pharmacol Chemother Date: 1954-03

7. Deoxybonucleic acid (DNA) and antibodies to DNA in the serum of patients with systemic lupus erythematosus.

Authors: E M Tan; P H Schur; R I Carr; H G Kunkel
Journal: J Clin Invest Date: 1966-11 Impact factor: 14.808

8. Acute poststreptococcal glomerulonephritis: immune deposit disease.

Authors: A F Michael; K N Drummond; R A Good; R L Vernier
Journal: J Clin Invest Date: 1966-02 Impact factor: 14.808

9. Experimental glomerulonephritis. The pathogenesis of a laboratory model resembling the spectrum of human glomerulonephritis.

Authors: F J DIXON; J D FELDMAN; J J VAZQUEZ
Journal: J Exp Med Date: 1961-05-01 Impact factor: 14.307

10. The pathologic effects of intravenously administered soluble antigen-antibody complexes. I. Passive serum sickness in mice.

Authors: R T MCCLUSKEY; B BENACERRAF; J L POTTER; F MILLER
Journal: J Exp Med Date: 1960-02-01 Impact factor: 14.307

10 in total

1. Routine assay for the detection of immune complexes of known immunoglobulin class using solid phase C1q.

Authors: F C Hay; L J Nineham; I M Roitt
Journal: Clin Exp Immunol Date: 1976-06 Impact factor: 4.330

2. Mechanism of histamine release from guinea-pig lung by soluble immune complexes. II. Role of anaphylatoxin.

Authors: I Broder
Journal: Immunology Date: 1974-01 Impact factor: 7.397

3. Mechanism of histamine release from perfused guinea-pig lung by soluble immune complexes. I. Complexes containing rabbit antibody.

Authors: I Broder; N S Taichman
Journal: Immunology Date: 1971-08 Impact factor: 7.397

4. Studies into the occurrence of soluble antigen-antibody complexes in disease. 3. Rheumatoid arthritis and other human diseases.

Authors: R Baumal; I Broder
Journal: Clin Exp Immunol Date: 1968-07 Impact factor: 4.330

5. Studies into the occurrence of soluble antigen-antibody complexes in disease. II. Criteria for distinguishing soluble complexes from other macromolecular histamine releasers.

Authors: I Broder; R Baumal; E Keystone
Journal: Clin Exp Immunol Date: 1968-07 Impact factor: 4.330

10. Studies into the occurrence of soluble antigen-antibody complexes in disease. IV. Correlation between the rheumatoid biologically active factor and the clinical features of rheumatoid arthritis.

Authors: D A Gordon; D A Bell; R Baumal; I Broder
Journal: Clin Exp Immunol Date: 1969-07 Impact factor: 4.330